To measure the concentration of carcinoembryonic antigen (CEA) in serial serum specimens of 47 healthy subjects and in serial sera of 59 patients with colorectal polyps of confirmed histology, obtained before or after (sometimes both) polypectomy, we used the Roche EIA and the Hybritech Tandem-E double monoclonal immunoenzymometric assays. Both methods gave comparable results for the healthy subjects but discordant values for some polyp patients. The Tandem-E test gave increased CEA results more frequently for two groups of polyp patients, the group of ex-smokers with neoplastic polyps (n = 14) and the group of smokers (n = 20). Smokers had significantly greater (P <0.025) mean concentrations of serum CEA than did nonsmokers, irrespective of whether they were healthy or had colorectal polyps. Smokers with recurrent polyps demonstrated significantly greater (P <0.050) mean concentrations of serum CEA than did smokers with a first occurrence of polyps. Polypectomy was followed by statistically significant decreases (P <0.050) of mean concentrations of serum CEA, pnmarily in polyp patients who were smokers. However, although CEA increases occurred frequently in polyp patients who smoked, these abnormalities did not fully correlate with polyp histology. patients (3-8) . However, several investigations failed to show a relationship between serum concentration of CEA and the presence of polyps (8,9). To clarify these conflicting data, we examined serum concentrations of CEA in patients with colorectal polyps. We also studied the individual and combined effects of polyp histology, polypectomy, smoking, and polyp recurrence on the mean concentrations of CEA.
To measure the concentration of carcinoembryonic antigen (CEA) in serial serum specimens of 47 healthy subjects and in serial sera of 59 patients with colorectal polyps of confirmed histology, obtained before or after (sometimes both) polypectomy, we used the Roche EIA and the Hybritech Tandem-E double monoclonal immunoenzymometric assays. Both methods gave comparable results for the healthy subjects but discordant values for some polyp patients. The Tandem-E test gave increased CEA results more frequently for two groups of polyp patients, the group of ex-smokers with neoplastic polyps (n = 14) and the group of smokers (n = 20). Smokers had significantly greater (P <0.025) mean concentrations of serum CEA than did nonsmokers, irrespective of whether they were healthy or had colorectal polyps. Smokers with recurrent polyps demonstrated significantly greater (P <0.050) mean concentrations of serum CEA than did smokers with a first occurrence of polyps. Polypectomy was followed by statistically significant decreases (P <0.050) of mean concentrations of serum CEA, pnmarily in polyp patients who were smokers. However, although CEA increases occurred frequently in polyp patients who smoked, these abnormalities did not fully correlate with polyp histology. (3) (4) (5) (6) (7) (8) . However, several investigations failed to show a relationship between serum concentration of CEA and the presence of polyps (8,9). To clarify these conflicting data, we examined serum concentrations of CEA in patients with colorectal polyps. We also studied the individual and combined effects of polyp histology, polypectomy, smoking, and polyp recurrence on the mean concentrations of CEA.
Materials and Methods

Specimensand Subjects
Serum specimens, prepared from blood that had been collected by venipuncture, were frozen at -70 #{176}C until used for the assay of CEA.
The controls were 47 subjects confirmed to be free from any gastrointestinal disease or other illnesses by medical exaniinntion and detailed reviews of their medical histories. Twenty-four of these individuals were men (ages 32-73 years; mean 55 years) and 23 were women (ages 30-67 years; mean 47 years). Twenty were nonsmokers, 18 were ex-smokers (i.e., had quit smoking for at least six months), and nine were smokers. A second blood sample was collected from 43 of these 47 subjects between 2.6 and 7.9 (mean 3.4) months after the initial blood collection.
The study group comprised 59 patients with colorectal polyps of defined histologies; 36 of these were having their first occurrence of polyps, the other 23 had recurrent polyps. Twenty-seven of the patients had hyperplastic polyps, and 32 had nonmalignant neoplastic adenomas with the following histologies: 21 adenomatons (tubular adenomas), seven villoglandular (tubulovillous adenomas), and four villous. Forty-two of the patients were men (ages 26-84 years; mean 55 years) and 17 were women (ages 37-77 years; mean 59 years).
Blood samples were collected from 31 of these 59 patients before and after a single polypectomy. The interval between blood collections ranged from 0.4 to 9.3 (mean 3.2) months. Only pre-polypectomy samples were obtained from nine patients and only post-polypectomy specimens were available from 13 others. For the remaining six patients, po8t-polypectomy samples were collected at an initial polypectomy and pre-polypectomy samples were collected at a second polypectomy.
CEA Assays
Concentrations
of CEA were measured in duplicate in each serum sample by two double-monoclonal iminunoenzymometric assays: the Roche EIA (lot no. 50057; Roche Diagnostic Systems, Nutley, NJ), designated here as a CEA-R, and the Hybritech Tandem-E (lot no. 591082; Hybritech Inc., San Diego, CA), designated here as CEA-H. Each CEA concentration reported is the mean of duplicate measurements. The assays were performed according to the manufacturers' test protocols with one exception: In the CEA-R assays, the Immunobeads and the peroxidase conjugate solutions were dispensed at a rate of 45 s per five tubes to synchronize with the speed of the Roche automated washer system. We repeated serum assays when the coefficient of variation (CV) between duplicate measurements exceeded 25%. CVs for the assays were <25% for CEA values that were within reference limits (up to 5-6 1g/L). They were typically <10% for CEA concentrations exceeding the upper reference limits.
StatisticalMethods
Mean concentrations of serum CEA in a single comparison of two populations were compared by Student's two-tailed t-test. When mean serum concentrations of CEA for more than two populations were compared, we applied the Tukey multiple-comparison test (10) , after one-way analysis of variance rejected the null hypothesis that all means were equal. The Tukey test appears to be robust with respect to departures from population normality and homogeneity of variance (11) , whereas the robustness of other multiple-comparison tests is not well known, and adverse effects of both Type I and Type H errors are possible if the assumptions about normality and homogeneity of variance are greatly violated. We compared the pre-and post-polypectomy mean concentrations of CEA by one-tailed paired-sample t-test to test the null hypothesis that the mean post-polypectomy CEA concentration was not less than the mean prepolypectomy CEA concentration. We used the one-tailed Dunnett's test (10, 12) to compare the means of more than one group with that of a control group. In all the statistical tests, P <0.05 was considered significant. Results 
and Discussion
Serum Concentration of CEA in Healthy Subjects
The CEA data were grouped on the basis of smoking history and classified according to the manufacturer's reference ranges defining the values as normal, borderline increased, or abnormal (increased). For CEA-R, these were <2.6,2.6-5.0, and >5.0 zg/L, respectively; for CEA-H, <3.1, 3.1-6.0, and >6.0 pgfL, respectively. For 43 of the healthy subjects, a second CEA value was determined at a later date (range 2.6 to 7.9 months). Concordant CEA results, i.e., CEA values falling into identical reference range groupings, were observed in 41 (87%) of the 47 subjects. In four of the cases, two by each CEA method, the repeat value did not correspond exactly with the initial value, resulting in assignment of the values to either a normal or an increased result. In the remaining discrepant cases, the CEA-H method reported CEA values to be abnormal in one case and borderline increased in another case, whereas the CEA-R method reported normal CEA values in each of these subjects.
The mean concentrations of serum CEA obtained at first blood collection for the healthy subjects are listed in Table 1 , as grouped by smoking histories. Both methods demonstrate statistically significant differences between smokers and both nonsmokers (P <0.025) and ex-smokers (CEA-R, P <0.010; CEA-H, P <0.005).
Serum Concentration of CEA in Polyp Patients
The CEA data were grouped according to polyp histology as well as smoking history. Serum specimens were collected from the 59 patients between 0.0 and 18.5 (mean 1.9) months before surgery and between 0.1 and 16.3 (mean 3.4) months after polypectomy; there were 52 pre-polypectomy and 54 post-polypectomy CEA values. By the CEA-R method, the pre-polypectomy CEA values were borderline increased in three patients, all with hyperplastic polyps (one nonsmoker and two smokers), and abnormal in one smoker with neoplastic polyps. The results for these four patients fell into the same classification by the CEA-H method. The remaining 48 pre-polypectomy CEA values were normal by the CEA-R method, whereas the CEA-H values were normal in only 40 of these 48 samples. The eight discrepant specimens, involving seven patients, were identified as borderline increased by the CEA-H method. Interestingly, in these discrepant cases, the patients were either previous or current smokers and six of the seven patients had neoplastic polyps.
Similar results were observed with the 54 post-polypectomy specimens. By the CEA-R method, only four post-polypectomy values were borderline increased or abnormal. In three of these four cases, the classification was the same by the CEA-H method. However, the CEA-H values were borderline increased in eight additional specimens, representing seven patients who were either ex-smokers or smokers. All but one of these patients had neoplastic polyps. Therefore, the CEA-H method showed a higher frequency of CEA abnormalities in polyp patients who were (ex-) smokers and usually those with neoplastic lesions, as well as in healthy smokers, than did the CEA-R method. Table 1 
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are CEA-R values, the latter may be a more specific marker of cancer. These observations merit study in a larger group of patients.
When the data were grouped on the basis of smoking history, ex-smokers with villous polyps had significantly greater mean concentrations of serum CEA-H than did ex-smokers with hyperplastic and adenomatous polyps (P <0.005). Both smoking and polyp history had a bearing on serum concentration of CEA. By either CEA method, smokers with recurrent polyps had significantly greater (P <0.050) mean concentrations of serum CEA than did smokers with first occurrence of polyps.
Polyp patients who were ex-smokers had mean concentrations of serum CEA-R that were significantly greater than the mean of healthy ex-smokers, irrespective of polyp histology (hyperplastic, P <0.010; adenomatous, P <0.025; viuloglandular, P <0.010; villous, P <0.001). Mean concentrations of serum CEA determined by the CEA-H method were significantly greater for polyp patients than for healthy subjects only in patients who were ex-smokers and for those who had the histologies of highest malignancy potential (villous, P <0.001, and villoglandular, P <0.050). There was no consistent change in the serum concentration of CEA before and after surgery at either polypectomy.
However, there was a tendency for the CEA concentrations at second polypectomies to be slightly lower than those at first polypectomies.
